Antibodies against oxidized phospholipids in laboratory tests exploring lupus anti-coagulant activity

Clinical and Experimental Immunology

Volumn 149, Issue 1, 2007, Pages 63-69

  Rolla, R ^a   Vidali, M ^a   Serino, R ^b   Pergolini, P ^b   Albano, E ^a   Bellomo, G ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b MAGGIORE DELLA CARITÀ HOSPITAL   (Italy)

Author keywords

2 glycoprotein 1; Anti phospholipid antibodies; Cardiolipin; Lipid peroxidation; Thrombosis

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; CARDIOLIPIN ANTIBODY; ENZYME ANTIBODY; IMMUNOGLOBULIN G; LUPUS ANTICOAGULANT; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLINOSITOL; PHOSPHATIDYLSERINE; PHOSPHOLIPID;

ADULT; AGED; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOASSAY; IMMUNOREACTIVITY; LABORATORY TEST; LIPID OXIDATION; LOGISTIC REGRESSION ANALYSIS; MALE; PARTIAL THROMBOPLASTIN TIME; PREDICTION; PRIORITY JOURNAL; SCREENING TEST; STATISTICAL SIGNIFICANCE;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTIPHOSPHOLIPID; AUTOANTIBODIES; FEMALE; HUMANS; IMMUNOGLOBULIN G; LIPID PEROXIDATION; LUPUS COAGULATION INHIBITOR; MALE; MIDDLE AGED; OXIDATION-REDUCTION; PARTIAL THROMBOPLASTIN TIME; PHOSPHATIDYLCHOLINES; PHOSPHATIDYLETHANOLAMINES; PHOSPHATIDYLINOSITOLS; PHOSPHATIDYLSERINES; PROTHROMBIN TIME;

EID: 34250213683     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2007.03404.x     Document Type: Article

References (32)

1. Bertolaccini ML, Hughes GR, Khamashta MA. Revisiting antiphospholipid antibodies: from targeting phospholipid to phospholipid binding proteins. Clin Lab 2004 50 : 653 65.
2. Pierangeli SS, Harris EN. Clinical laboratory testing for antiphospholipid syndrome. Clin Chim Acta 2005 357 : 17 23.
3. Levine JS, Branch DW, Rauch J. The antiphospholipid syndrom. N Engl J Med 2003 346 : 752 63.
4. McNeil HP, Chesterman CN, Krilis SA. Immunological and clinical importance of antiphospholipid antibodies. Adv Immunol 1991 49 : 193 280.
5. Veres K, Lakos G, Kerenyi A et al. Antiphospholipid antibodies in acute coronary syndrome. Lupus 2004 13 : 423 7.
6. Katzav A, Chapman J, Shoenfeld Y. CNS dysfunction in the antiphospholipid syndrome. Lupus 2003 12 : 903 7.
7. Kearon C. Epidemiology of venous thromboembolism. Semin Vasc Med 2001 1 : 7 26.
8. Passam FH, Krilis SA. Laboratory tests for the antiphospholipid syndrome: current concepts. Pathology 2004 36 : 129 38.
9. Wong RC, Adelstein S, Gillis D, Favaloro EJ. Development of consensus guidelines for anticardiolipin and lupus anticoagulant testing. Semin Thromb Hemost 2005 31 : 39 48.
10. Derksen HMW, de Groot PG. Tests for lupus anticoagulant revisited. Thomb Res 2004 114 : 521 6.
11. Roubey RA, Pratt CW, Boyson JP, Winfield JB. Lupus anticoagulant activity of autoimmune antiphospholipid antibodies is dependent upon beta 2-glycoprotein. J Clin Invest 1992 90 : 1100 4.
12. Oosting JD, Derksen RH, Bobbink IW et al. Antiphospholipid antibodies directed against a combination of phospholipid with prothombin, protein C, or protein S: an explanation for their pathogenetic mechanisms? Blood 1993 81 : 2618 25.
13. Hörkkö S, Miller E, Dudl E et al. Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein. J Clin Invest 1996 98 : 815 25.
14. Hörkkö S, Miller E, Branch DW et al. The epitopes for some antiphospholipid antibodies are adducts of oxidized phospholipid and β2-glycoprotein 1 (and other proteins). Proc Natl Acad Sci USA 1997 94 : 10356 61.
15. Vaarala O, Alfthan G, Jauhiainen M et al. Cross reaction between antibodies to oxidized low density lipoproteins and to cardiolipin in lupus erythematosus. Lancet 1993 341 : 923 5.
16. Vaarala O, Puurunen M, Lukka M et al. Affinity purified cardiolipin-binding antibodies show heterogeneity in their binding to oxidized low density lipoproteins. Clin Exp Immunol 1996 104 : 269 74.
17. Chang MK, Binder CJ, Miller YI et al. Apoptotic cells with oxidation-specific epitopes are immunogenic and proinflammatory. J Exp Med 2004 11 : 1359 70.
18. Kilpatrick DC. Factors affection cardiolipin antibody assays: modification with polyethylene glycol compound. Br J Haematol 1998 100 : 52 7.
19. Greaves M. Antiphospholipid antibodies and thrombosis. Lancet 1999 353 : 1348 53.
20. Galli M, Luciani D, Bertolini G et al. Lupus anticoagulants are stronger risk factors of thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood 2003 101 : 1827 32.
21. Rand JH. Molecular pathogenesis of the antiphospholipid syndrome. Circ Res 2002 90 : 29 37.
22. Zoghlami-Rintelen C, Vormittag R, Sailer T et al. The presence of IgG antibodies against beta2-glycoprotein I predicts the risk of thrombosis in patients with the lupus anticoagulant. J Thromb Haemost 2005 3 : 1160 5.
23. Takeya H, Mori T, Gabazza EC, Kuroda F et al. Anti-beta2glycoprotein I (beta2GPI) monoclonal antibodies with lupus anticoagulant like activity enhances the beta2GPI binding to phospholipids. J Clin Invest 1997 99 : 2260 8.
24. Amengual O, Atsumi T, Koike T. Antiprothrombin antibodies and the diagnosis of the antiphospholipid syndrome. Clin Immunol 2004 112 : 144 9.
25. Atsumi T, Ieko M, Bertolaccini ML et al. Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant. Arthritis Reumatol 2000 43 : 1982 93.
26. Simmelink MJA, Derksen RMWM, Arnout J et al. A simple methods to discriminate between β2-glycoprotein 1- and prothrombin-dependent lupus anticoagulants. J Thromb Haemost 2003 1 : 740 7.
27. Miyakis S, Lockshin MD, Atsumi T et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006 4 : 295 306.
28. Rauch J, Tannenbaum M, Neville C et al. Inhibition of lupus anticoagulant activity by hexagonal phase phosphatidylethanolamine in the presence of prothrombin. Thromb Haemost 1998 80 : 936 41.
29. McIntyre JA, Wagenknecht DR. Anti-phosphatidylethanolamine (aPE) antibodies: a survey. J Autoimmun 2000 15 : 185 93.
30. Rolla R, Vay D, Mottaran E et al. Anti-phospholipid antibodies associated with alcoholic liver disease specifically recognize oxidized phospholipids. Gut 2001 49 : 852 9.
31. Rigamonti C, Mottaran E, Reale E et al. Moderate alcohol consumption increases oxidative stress in patients with chronic hepatitis C. Hepatology 2003 38 : 42 9.
32. Schlame M, Haller I, Sammaritano LR, Blank TJJ. Effect of cardiolipin oxidation on solid-phase immunoassay for antiphospholipid antibodies. Thromb Haemost 2001 86 : 1475 82.